Vaccination in adults with auto-immune disease and/or drug related immune deficiency: Results of the GEVACCIM Delphi survey

被引：15

作者：

Duchet-Niedziolka, P. ^{[1
,2
]}

Launay, O. ^{[1
,2
]}

Coutsinos, Z. ^{[1
,2
]}

Ajana, F. ^{[3
]}

Arlet, P. ^{[4
]}

Barrou, B. ^{[5
]}

Beytout, J. ^{[6
]}

Bouchaud, O. ^{[7
]}

Brouqui, P. ^{[8
,9
]}

Buzyn, A. ^{[10
]}

Chidiac, C. ^{[11
]}

Couderc, L. J. ^{[12
]}

Debord, T. ^{[13
]}

Dellamonica, P. ^{[14
]}

Dhote, R. ^{[15
]}

Duboust, A. ^{[16
]}

Durrbach, A. ^{[17
]}

Fain, O. ^{[18
]}

Fior, R. ^{[19
]}

Godeau, B. ^{[20
]}

Goujard, C. ^{[21
]}

Hachulla, E. ^{[22
]}

Marchou, B. ^{[23
]}

Mariette, X. ^{[24
]}

May, T. ^{[25
]}

Meyer, O. ^{[26
]}

Milpied, N. ^{[27
]}

Morlat, P. ^{[28
]}

Pouchot, J. ^{[29
]}

Tattevin, P. ^{[30
]}

Viard, J. P. ^{[31
]}

Lortholary, O. ^{[32
,33
,34
]}

Hanslik, T. ^{[7
,35
]}

机构：

[1] Univ Paris 05, Fac Med, Paris, France

[2] INSERM, CIC BT505, Paris, France

[3] Ctr Hosp Dron, Serv Univ & Reg Malad Infectieuses & Conseils Voy, Tourcoing, France

[4] Serv Med Interne, Toulouse, France

[5] Grp Hosp Pitie Salpetriere, AP HP, Serv Urol, F-75634 Paris, France

[6] CHU Clermont Ferrand, Serv Malad Infect, Clermont Ferrand, France

[7] Univ Paris 13, AP HP, Bobigny, France

[8] Univ Nord, AP HM, Serv Malad Infect, Ctr Hosp, Marseille, France

[9] Univ Nord, Trop Ctr Vaccinat Voyageur, Ctr Hosp, Marseille, France

[10] Hop Necker Enfants Malad, AP HP, Serv Hematol, Paris, France

[11] Hop Croix Rousse, Serv Malad Infect & Trop, F-69317 Lyon, France

[12] Hop Foch, Serv Pneumol, Suresnes, France

[13] Hop Mil Begin, Serv Malad Infect & Trop, St Mande, France

[14] Univ Nice Sophia Antipolis, Fac Med, Nice, France

[15] Hop Avicenne, AP HP, Serv Med Interne, F-93009 Bobigny, France

[16] Hop St Louis, AP HP, Serv Nephrol, Paris, France

[17] Univ Paris 11, INSERM, U542, Le Kremlin Bicetre, France

[18] Hop Jean Verdier, AP HP, Serv Med Interne, Bondy, France

[19] Hop Antoine Beclere, AP HP, Serv Med Interne & Immunol Clin, Clamart, France

[20] Univ Paris 12, AP HP, Serv Med Interne, Creteil, France

[21] Hop Bicetre, AP HP, Serv Med Interne, Le Kremlin Bicetre, France

[22] Hop Claude Huriez, Ctr Reference Malad Autoimmunes & Malad Syst Rare, Serv Med Interne, Lille, France

[23] Hop Purpan, Serv Malad Infect & Trop, Toulouse, France

[24] Univ Paris 11, INSERM, U802, Hop Bicetre, Le Kremlin Bicetre, France

[25] Hop Brabois, Serv Malad Infect & Trop, Vandoeuvre Les Nancy, France

[26] Hop Bichat Claude Bernard, AP HP, Serv Rhumatol, F-75877 Paris, France

[27] CHU Bordeaux, Serv Malad Sang, Bordeaux, France

[28] Univ Bordeaux 2, F-33076 Bordeaux, France

[29] Hop Europeen Georges Pompidou, AP HP, Serv Med Interne, Paris, France

[30] CHU Pontchaillou, Serv Malad Infect & Reanimat Med, Rennes, France

[31] Hop Necker Enfants Malad, AP HP, Serv Immunol Clin Adultes, Paris, France

[32] Hop Necker Enfants Malad, AP HP, Serv Malad Infect & Trop, Paris, France

[33] Hop Ambroise Pare, AP HP, Serv Med Interne, F-92100 Boulogne Billancourt, France

[34] Univ Versailles St Quentin Yvelines, F-78000 Versailles, France

[35] Univ Paris 06, INSERM, UPMC, UMR S 707, F-75005 Paris, France

来源：

VACCINE | 2009年 / 27卷 / 10期

关键词：

Vaccination; Immunocompromised adults; Auto-immune disease; Delphi survey; Immunosuppressants; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PNEUMOCOCCAL POLYSACCHARIDE VACCINE; RHEUMATOID-ARTHRITIS; INFLUENZA IMMUNIZATION; ANTIBODY-RESPONSE; HEPATITIS-B; TRANSPLANT RECIPIENTS; DOUBLE-BLIND; RISK; INFECTION;

D O I：

10.1016/j.vaccine.2009.01.003

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Introduction: There are insufficient data regarding the efficacy and safety of vaccination in patients with auto-immune disease (AID) and/or drug-related immune deficiency (DRID). The objective of this study was to obtain professional agreement on vaccine practices in these patients. : A Delphi Survey was carried out with physicians recognised for their expertise in vaccinology and/or the caring for adult patients with AID and/or DRID. For each proposed vaccination practice, the experts' opinion and level of agreement were evaluated. Results: The proposals relating to patients with AID specified: the absence of risk of AID relapse following vaccination; the possibility of administering live virus vaccines (LVV) to patients not receiving immunosuppressants: the pertinence of determining protective antibody titre before vaccination; the absence of need for specific monitoring following the vaccination. The proposals relating to patients with DRID specified that a 3-6 month delay is needed between the end of these treatments and the vaccination with LVV. There is no contraindication to administering LVV in patients receiving systemic corticosteroids prescribed for less than two weeks, regardless of their dose, or at a daily dose not exceeding 10 mg of prednisone, if this involves prolonged treatment. Out of 14 proposals, the level of agreement between the experts was "very good" for eleven, and "good" for the remaining three. Conclusion: Proposals for vaccine practices in patients with AID and/or DRID should aid with decision-making in daily medical practice and provide better vaccine coverage for these patients. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：1523 / 1529

页数：7

共 74 条

[1]

Abu-Shakra M, 2002, J RHEUMATOL, V29, P2555

[2]

Abu-Shakra M, 2000, J RHEUMATOL, V27, P1681

[3]

*ACIP, 2005, MMWR RECOMM REP

[4]

[Anonymous], 2000, MMWR Recomm Rep, V49, P1

[5]

[Anonymous], 1993, MMWR Recomm Rep, V42, P1

[6]

ARMSTRONG D, 1991, REV INFECT DIS, V13, pS763

[7]

ATKINSON WL, 2002, MMWR RECOMM REP, V51, P22

[8]

Battafarano DF, 1998, ARTHRITIS RHEUM, V41, P1828, DOI 10.1002/1529-0131(199810)41:10<1828::AID-ART15>3.3.CO

[9]

2-K

[10] Management of spontaneous pneumothorax - An American College of Chest Physicians Delphi Consensus Statement [J].

Baumann, MH ;

Strange, C ;

Heffner, JE ;

Light, R ;

Kirby, TJ ;

Klein, J ;

Luketich, JD ;

Panacek, EA ;

Sahn, SA .

CHEST, 2001, 119 (02) :590-602

← 1 2 3 4 5 6 7 8 →